Document is current
Any future updates will be listed below
-
Authors
Sun, Zhixuan
Chen, Yujie
Ding, Pengbing
Wang, Zheng
Lin, Zhiyu
Zhou, Binyi
Hu, Fengyi
Lu, Enhang
Xiang, Haibo
Yang, Xin
Zhang, Peiyang
Zhao, Zhenmin https://orcid.org/0000-0002-7177-2169
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No. 82402945)
- License Information
-
More Information
Article History
Received: 28 April 2025
Accepted: 11 June 2025
First Online: 1 July 2025
Declarations
:
: All animal experiments for this study were in accordance with the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines 2.0. All animal procedures and protocols were approved by the Experimental Animal Ethics Committee of Peking University Third Hospital (approval number: SA2022341; date of approval: March 7, 2022; title of approved project: “Distraction force promotes the osteogenesis in facial sutures”). HL-60 cells (cat. CL-0110) were bought from Wuhan Pricella Biotechnology Co. (Wuhan, China). The HL-60 cell line was established in 1977 from a female patient with acute myeloid leukemia [, ]. It has been used for decades to study normal myeloid differentiation and leukemia biology, and many studies have used HL-60 cells from Pricella [, ]. According to the 2016 ISSCR Guidelines for Stem Cell Research and Clinical Translation, the use of historical cell lines from pathological specimens are permissible for use in stem cell research.
: Not applicable.
: The authors declare no competing interests.
